Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001056520-11-000482
Filing Date
2011-11-08
Accepted
2011-11-08 17:02:39
Documents
9
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cellcyteform10qsept302011fin.htm 10-Q 278406
2 CERTIFICATION exhibit31.htm EX-31 12265
3 CERTIFICATION exhibit32.htm EX-32 5039
  Complete submission text file 0001056520-11-000482.txt   1353235

Data Files

Seq Description Document Type Size
4 INSTANCE ccyg-20110930.xml EX-101.INS 173684
5 SCHEMA ccyg-20110930.xsd EX-101.SCH 7917
6 CALCULATIONS ccyg-20110930_cal.xml EX-101.CAL 5216
7 DEFINITIONS ccyg-20110930_def.xml EX-101.DEF 6031
8 LABELS ccyg-20110930_lab.xml EX-101.LAB 87026
9 PRESENTATION ccyg-20110930_pre.xml EX-101.PRE 64956
Mailing Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006
Business Address PMB189 14205 SE 36TH, SUITE 100 BELLEVUE WA 98006 425-519-3755
CELLCYTE GENETICS CORP (Filer) CIK: 0001325279 (see all company filings)

EIN.: 861127046 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52238 | Film No.: 111188531
SIC: 2834 Pharmaceutical Preparations